๐ฐ Bph News
Page 56 - Bph News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bph. Real-time updates on events, politics, business and more.
December 24, 2023
NUNA, a world leader in premium baby gear, has announced the opening of its first flagship store in the Philippines.
December 24, 2023
AGGRESSIVE monetary policy tightening has not unduly affected the overall growth momentum of Philippine economic growth, Bangko Sentral ng Pilipinas (BSP) Governor Eli Remolona Jr. told reporters last week.
December 24, 2023
ECONOMIC growth in most of emerging Asia, including the Philippines, will likely slow in the near term given subdued global demand and elevated interest rates, Capital Economics said in a report.
December 23, 2023
MANILA, Philippines: The northeast monsoon, locally known as amihan, and the shear line โ where the hot and cold air converge โ are likely to bring significant rain in parts of the country over the next three days, the state-run weather agency said on Saturday.
December 23, 2023
MANILA, Philippines: Drita Ziri of Albania was crowned Miss Earth 2023 while the Philippines bet, Yllana Aduana, came in second with the Miss Earth Air title after Friday nights coronation held in Ho Chi Minh City, Vietnam.
December 23, 2023
MANILA, Philippines: The Bureau of Immigration (BI) sees a major surge in passenger arrivals with some 1,5 million visitors expected in the country during the Christmas holiday as international travel continues to gain momentum..
December 22, 2023
Dana-Farber Cancer Institute has reinstituted a mask mandate, as COVID cases spike and respiratory infections jump across Massachusetts.
December 22, 2023
OneAscent Financial Services LLC bought a new position in shares of Parker-Hannifin Co. (NYSE:PH – Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 779 shares of the industrial products company’s stock, valued at approximately $303,000. A number of other […]
December 22, 2023
The FDA has approved label updates for zanubrutinib to include data from the ALPINE trial in relapsed/refractory chronic lymphocytic leukemia, and axicabtagene ciloleucel to include findings from the primary overall survival analysis of the ZUMA-7 trial in relapsed/refractory large B-cell lymphoma.